Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04025814 · ClinicalTrials.gov registry record · NA

dHealth Solution for Improving Parent Adherence to Behavioral Treatment for ADHD

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
73
Enrollment target
1
Study location

NCT04025814 is a NA study of Attention Deficit Hyperactivity Disorder that has completed, run by University of California, San Francisco. The registered enrollment target is 73 participants, below the 206-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04025814, a NA study of Attention Deficit Hyperactivity Disorder, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
73 participants
Enrollment target
1
Study location

Study Summary

This study aims to develop, refine and preliminarily test a novel and scalable digital health solution designed to address parent adherence barriers in daily life contexts and increase parent's sustained use of evidence-based parenting strategies.

Interventions

  • DEVICE CaregiverAssist
  • BEHAVIORAL Behavioral Parent Training (CLS Parent Group)

Study Locations (1)

California

  • HALP Clinic, Children's Center at Langley Porter, UCSF - San Francisco

Trial Details

FieldValue
Enrollment Target 73 participants
Start Date 2020-08-01
Est. Completion 2024-11-12
Phase NA

What the Registry Record Tells You About NCT04025814

The ClinicalTrials.gov registry entry for NCT04025814 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 206-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (65% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 2 interventions - of which CaregiverAssist is the first listed.

NCT04025814 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04025814 about?

NCT04025814 is a clinical study titled "dHealth Solution for Improving Parent Adherence to Behavioral Treatment for ADHD". This study aims to develop, refine and preliminarily test a novel and scalable digital health solution designed to address parent adherence barriers in daily life contexts and increase parent's sustained use of evidence-based parenting strategies.

What is the current status of trial NCT04025814?

This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2020-08-01. Estimated completion is 2024-11-12.

What conditions does trial NCT04025814 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT04025814?

The interventions under investigation include: CaregiverAssist (DEVICE), Behavioral Parent Training (CLS Parent Group) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04025814?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04025814 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.